Profiel
Cynthia Pussinen served as the Chief Executive Officer & Director at Sernova Corp.
from 2023 to 2024.
Prior to that, she was the Chief Technical Officer at Spark Therapeutics, Inc. from 2021 to 2022.
She also held the position of Executive Vice President-Technical Development at Actinium Pharmaceuticals, Inc. Ms. Pussinen holds a graduate degree from Rensselaer Polytechnic Institute and an undergraduate degree from the University of Connecticut.
Eerdere bekende functies van Cynthia Pussinen
| Bedrijven | Functie | Einde |
|---|---|---|
| SERNOVA BIOTHERAPEUTICS INC | Algemeen Directeur | 12-08-2024 |
| SPARK THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-12-2022 |
| ACTINIUM PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Opleiding van Cynthia Pussinen
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Sernova Biotherapeutics, Inc.
Sernova Biotherapeutics, Inc. BiotechnologyHealth Technology Develops life science products | Health Technology |
Rensselaer Polytechnic Institute
Rensselaer Polytechnic Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Connecticut
University of Connecticut Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Actinium Pharmaceuticals, Inc.
Actinium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company developing targeted payload immunotherapeutic for the treatment of advanced cancers | Health Technology |
Spark Therapeutics, Inc.
Spark Therapeutics, Inc. BiotechnologyHealth Technology Develops therapy products for debilitating diseases | Health Technology |
















